Scilex Holding (SCLX) FCF Margin Growth (3y) (2025 - 2026)
Scilex Holding (SCLX) FCF Margin Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.29 Bn | 631.53 Bn | 17.26 Bn | 1,461.00 |
| 2 | AbbVie | 469.70 Bn | 463.14 Bn | 12.70 Bn | -2,596.00 |
| 3 | Merck | 374.92 Bn | 367.78 Bn | 12.21 Bn | 874.00 |
| 4 | Novartis Ag | 302.99 Bn | 295.30 Bn | 11.24 Bn | 536.00 |
| 5 | Astrazeneca | 257.60 Bn | 252.70 Bn | 12.86 Bn | -1,444.00 |
| 6 | Amgen | 236.63 Bn | 222.64 Bn | 7.24 Bn | -2,024.00 |
| 7 | Gilead Sciences | 182.46 Bn | 179.28 Bn | 6.22 Bn | 1,067.00 |
| 8 | Pfizer | 159.59 Bn | 147.89 Bn | 10.94 Bn | 6,281.00 |
| 9 | Gsk | 106.12 Bn | 101.95 Bn | 8.24 Bn | -1,843.00 |
| 10 | Scilex Holding | 39.10 Mn | -73.69 Mn | 3.97 Mn | 1,537.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,385.00 |
| Dec 31, 2025 | -35,493.00 |
| Sep 30, 2025 | 5,241.00 |
| Jun 30, 2025 | 22,687.00 |
| Mar 31, 2025 | 27,767.00 |